Dr. Alfredo D. Voloschin, MD

Dr. Voloschin practices at Arnold Palmer Hospital for Children in Orlando, Florida.

Dr. Voloschin's NPI, 1376654376, was assigned on August 31, 2006. Dr. Voloschin graduated from University of Buenos Aires in 1985. Dr. Voloschin holds Florida license ME70185.

Dr. Voloschin's primary practice is Arnold Palmer Hospital for Children, at 92 W Miller St, Orlando, FL 32806 in Orange County. The practice phone is (407) 650-5028.

Dr. Voloschin's primary practice is Arnold Palmer Hospital for Children in Orlando, Florida. Dr. Voloschin is also affiliated with Orlando Regional Medical Center. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Voloschin to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Voloschin practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Voloschin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Voloschin is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Voloschin's licenses on file in 2 states: Florida and Georgia.

CMS data shows 143 Medicare services from Dr. Voloschin across 3 procedure codes in 2024, all of them office visits, for 71 Medicare patients. Medicare paid $13,186 for them.

CMS counts 71 Medicare patients who saw Dr. Voloschin in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 21% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Voloschin's median patient age at 63, with 53% women.

In 2024, Dr. Voloschin wrote 259 Medicare Part D claims for 56 patients. 90% of them were for generic drugs. CMS names the drug for 176 of them, across 6 drugs with 11 or more claims each, at $32,230 in total drug cost. In 2023, CMS named 62 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Voloschin for performance year 2024, reported as part of a group. Dr. Voloschin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Voloschin as offering telehealth.

Dmand AI links 26 papers to Dr. Voloschin, published from 2007 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Brain Neoplasms, Glioblastoma and Magnetic Resonance Imaging. Dr. Voloschin has published most often in Tomography. Dr. Voloschin's most frequent co-authors are Hui-Kuo George Shu, MD, Brent Derek Weinberg, MD and Ian Crocker, MD.

Dmand AI links Dr. Voloschin to 6 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Glioblastoma, Gliosarcoma and Astrocytoma.

CMS Open Payments shows 11 general payments to Dr. Voloschin from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $1,028.

Dr. Voloschin graduated from University of Buenos Aires in 1985.

Dr. Voloschin is in network with 16 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.